Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch
Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. A look at what 2024 might
Read More
NASDAQ Biotechnology Index
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Shares of other biotech companies developing ADCs, which are among the hottest areas in the pharmaceutical industry, jumped on the
Read More
Bank of America just added these biotech stocks to its list of first-quarter picks
The biotech sector is hot on Wall Street right now. Here are some of Bank of America's favorite stocks going
Read More